Sign in Subscribe
Genetic research

Breakthrough in Nanotechnology: Asynchronous-Regulated Nanosheet for Intensive Tumor Immunotherapy

Strategic Insights

— 1 min read

Research conducted by Sichuan University has led to the development of an ultrasound-activated nanosheet that induces potent DNA damage in tumors, enabling effective immunotherapy. The study showed that the nanosheet, named ECHO, achieved a 87% tumor regression and 40% contralateral bilateral tumor elimination in a mouse model. The research utilized an asynchronous regulation strategy that amplified sonodynamic-triggered self-enhanced DNA damage, intensifying tumor immunotherapy. This breakthrough has significant implications for the treatment of cancer, particularly for tumors that are resistant to traditional therapies.

Key Takeaways:

  • Sichuan University researchers developed an ultrasound-activated nanosheet (ECHO) that induces potent DNA damage in tumors.
  • The ECHO nanosheet achieved a 87% tumor regression and 40% contralateral bilateral tumor elimination in a mouse model.
  • The asynchronous regulation strategy amplified sonodynamic-triggered self-enhanced DNA damage, intensifying tumor immunotherapy.
  • The ECHO nanosheet leveraged the Russell mechanism to continuously generate ROS within the tumor microenvironment, heightening cellular susceptibility to DNA damage.
  • The study showed that the ECHO nanosheet effectively targeted tumors with minimal adverse effects.
  • The asynchronous regulation strategy disrupted ROS clearance, allowing for increased ROS content and restrained DNA repairing.
  • The study concluded that the ECHO nanosheet offers a promising prototype for intensive tumor immunotherapy.

Statistics:

  • 87% tumor regression rate achieved by the ECHO nanosheet
  • 40% contralateral bilateral tumor elimination rate achieved by the ECHO nanosheet
  • 90% of the tumor cells were killed by the ECHO nanosheet in a 24-hour period

Sources:

  • An Asynchronous-Regulated Nanosheet Cascade Amplifies Sonodynamic-Triggered Self-Enhanced DNA Damage for Intensive Tumor Immunotherapy. ACS Nano, 2025.
  • NewsRx. Sichuan University Reports Findings in Nanosheets (An Asynchronous-Regulated Nanosheet Cascade Amplifies Sonodynamic-Triggered Self-Enhanced DNA Damage for Intensive Tumor Immunotherapy). Nanotechnology Weekly. July 14, 2025; p 1452.

Read more